Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 vaccines do not increase the risk of alopecia areata.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

ILC1-like cells may contribute to hair loss in alopecia areata.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Combining specific inducers helps dermal papilla cells regain hair-forming ability.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.